Sign in

CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
  1. 4 Open-market sale SVP, Chief Scientific Officer sold 25,000 shares at $4.97 ($124,250)
  2. 4 Open-market sale SVP, Chief Medical Officer sold 15,968 shares at $4.68 ($74,730)
  3. 4 Shares withheld for taxes Chief Business Officer gave up 1,724 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Business Officer gave up 1,149 shares (to pay taxes)
  5. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 7,534 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 9,032 shares (to pay taxes)
  7. 4 Grant or award Director acquired 4,610 shares (grant or award)
  8. 4 Grant or award Director acquired 4,610 shares (grant or award)
  9. 4 Grant or award Director acquired 4,610 shares (grant or award)
  10. 4 Grant or award Director acquired 4,610 shares (grant or award)
  11. 4 Grant or award Director acquired 4,610 shares (grant or award)
  12. 4 Grant or award Chief Business Officer acquired 15,000 shares (grant or award)
  13. 4 Grant or award SVP, Chief Medical Officer acquired 108,000 shares (grant or award)
  14. 4 Grant or award SVP, Chief Commercial Officer acquired 16,000 shares (grant or award)
  15. 4 Grant or award SVP, Chief Scientific Officer acquired 19,000 shares (grant or award)
  16. 4 Grant or award Chairman & CEO acquired 165,500 shares (grant or award)
  17. 4 Grant or award SVP, Chief Financial Officer acquired 96,500 shares (grant or award)
  18. 4 Grant or award VP of Business Dev't acquired 10,000 shares (grant or award)
  19. 4 Open-market sale 10% owner sold 500,000 shares at an average $5.58 ($2,791,290)
  20. 4 Open-market sale Former 10% holder sold 175,000 shares at $25.30 ($4,427,500)

Page 6 of 9 · 180 filings